A patient with poorly controlled diabetes presents with symptoms suggestive of peripheral neuropathy and peripheral artery disease, as well as a plantar ulcer on the right foot. Which of the following nursing interventions is the most appropriate to prevent further complications and promote healing of the ulcer?

B) Instruct the patient to keep the ulcer clean and dry, and to report any signs of infection promptly.

A) Encourage the patient to increase physical activity to improve circulation.

B) Instruct the patient to keep the ulcer clean and dry, and to report any signs of infection promptly.

C) Advise the patient to apply a moisturizing cream to the area around the ulcer daily to maintain skin integrity.

D) Recommend the use of compression stockings to reduce edema and improve venous return.

A 68-year-old patient with poorly controlled diabetes presents with persistent leg cramps, a foot ulcer, and signs of peripheral neuropathy. During a follow-up visit, the nurse is tasked with formulating a care plan. Which nursing intervention should be prioritized to address the patient's current complications?

A) Educate the patient on the importance of tight glycemic control and regular foot inspection.

B) Administer prescribed pain medication to manage neuropathic pain.

C) Schedule the patient for immediate revascularization to improve pedal pulses.

D) Refer the patient to a social worker for assistance with medication costs.

A patient with diabetes and peripheral neuropathy is being managed with a multidisciplinary approach. Despite some improvements, the patient shows inconsistent compliance with foot care education. Which nursing intervention is most appropriate to enhance the patient's adherence to foot care recommendations?

C) Implement a goal-setting session to establish achievable foot care routines.

A) Schedule daily home visits by a nurse to assist with foot care.

B) Provide the patient with written materials on foot care techniques.

C) Implement a goal-setting session to establish achievable foot care routines.

D) Refer the patient to a support group for individuals with diabetic foot complications.

A patient with a plantar ulcer and diabetes shows signs of granulation tissue after two weeks of podiatric intervention. However, their compliance with foot care education is inconsistent. Which nursing intervention is most appropriate to enhance the patient's adherence to foot care instructions?

C) Engage the patient in a motivational interview to explore barriers and enhance self-efficacy.

A) Schedule daily home visits by a community nurse to assist with foot care.

B) Provide the patient with detailed printed instructions on foot care techniques.

C) Engage the patient in a motivational interview to explore barriers and enhance self-efficacy.

D) Arrange for the patient to attend a weekly diabetes education class.

A patient with diabetes and hypertension is experiencing worsening nephropathy. The patient's blood pressure is consistently elevated despite current treatment, and laboratory results show significant albuminuria. The healthcare team decides to introduce an ACE inhibitor. What is the primary reason for selecting an ACE inhibitor in this scenario?

C) ACE inhibitors help protect renal function by reducing glomerular pressure.

A) ACE inhibitors directly lower LDL cholesterol levels.

B) ACE inhibitors improve insulin sensitivity.

C) ACE inhibitors help protect renal function by reducing glomerular pressure.

D) ACE inhibitors increase urine output to decrease blood pressure.

A 60-year-old patient with diabetes and recent hypertension is being managed with an ACE inhibitor for renal protection and blood pressure control. The recent lab results indicate elevated LDL cholesterol and triglycerides, prompting the healthcare team to consider statin therapy. What is the most critical nursing intervention to ensure the patient's safety after starting the new medications?

D) Schedule regular follow-up appointments for liver function tests.

A) Monitor the patient's blood pressure daily at home.

B) Educate the patient about potential muscle pain as a side effect of statins.

C) Encourage the patient to increase dietary potassium intake.

D) Schedule regular follow-up appointments for liver function tests.

A patient on an ACE inhibitor for hypertension is experiencing a persistent dry cough, and the healthcare team is considering switching to an ARB. Additionally, the patient has reported symptoms of mild peripheral neuropathy with a recent HbA1c level of 8.2%. Which nursing action is most appropriate to address the patient's current symptoms and treatment concerns?

B) Educate the patient on the potential benefits of switching to an ARB and discuss the importance of glycemic control to prevent neuropathy progression.

A) Advise the patient to stop the ACE inhibitor immediately to alleviate the cough and consult the physician for an alternative.

B) Educate the patient on the potential benefits of switching to an ARB and discuss the importance of glycemic control to prevent neuropathy progression.

C) Suggest the patient increase their statin dose to further improve lipid levels and focus on lifestyle modifications.

D) Recommend the patient use over-the-counter cough suppressants to manage the side effect of the ACE inhibitor.

A patient with hypertension, dyslipidemia, and diabetes mellitus is experiencing a persistent dry cough after starting an ACE inhibitor. The patient also reports mild peripheral neuropathy symptoms, and the HbA1c level is 8.2%. Which action should the nurse prioritize to address the patient's current concerns?

A) Educate the patient about the potential switch from ACE inhibitor to ARB to alleviate the cough.

B) Discuss the addition of a medication to better manage the patient's blood glucose levels.

C) Reinforce the importance of adhering to the current medication regimen to prevent cardiovascular complications.

D) Suggest lifestyle modifications to improve overall health and reduce medication burden.

A patient with type 2 diabetes has been started on an SGLT2 inhibitor to improve glycemic control. The nurse notes the patient reports increased fatigue and dizziness upon standing. Which nursing intervention is most appropriate to address these symptoms?

A) Increase the patient's fluid intake and advise on postural changes

B) Discontinue the SGLT2 inhibitor and notify the healthcare provider immediately

C) Encourage the patient to consume more carbohydrates to prevent hypoglycemia

D) Suggest the patient take antihypertensive medication at bedtime to prevent dizziness

A patient with type 2 diabetes and hypertension is being treated with an SGLT2 inhibitor and reports symptoms of dizziness upon standing. What is the most appropriate nursing action to address the patient's symptoms?

B) Educate the patient about maintaining hydration and rising slowly from seated positions

A) Increase the dose of the SGLT2 inhibitor

B) Educate the patient about maintaining hydration and rising slowly from seated positions

C) Discontinue the antihypertensive medication immediately

D) Advise the patient to reduce physical activity until symptoms resolve

Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance leads to impaired glucose uptake by cells, causing hyperglycemia. In type 1 diabetes, autoimmune destruction of pancreatic beta cells results in insulin deficiency, while in type 2 diabetes, tissues become resistant to insulin's effects.

• Secondary mechanism: Persistent hyperglycemia triggers advanced glycation end products (AGEs) formation, which damage blood vessels and tissues by promoting inflammation and oxidative stress, leading to complications.

• Key complication: Chronic hyperglycemia results in microvascular complications (retinopathy, nephropathy, neuropathy) and macrovascular complications (atherosclerosis), significantly impacting patient quality of life and increasing morbidity and mortality.

Patient Profile

Demographics:

58-year-old male, retired factory worker

History:

• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 40 mg once daily, Aspirin 81 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in feet

• Key symptoms: Fatigue, blurred vision, frequent urination, occasional dizziness

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 210 mg/dL

Section 1

New Complications:

During a follow-up appointment, the patient's symptoms have escalated. He now reports persistent leg cramps, especially at night, and has developed a small ulcer on the plantar surface of his right foot. His family notes that he has been increasingly irritable and forgetful. A thorough physical examination reveals diminished pedal pulses and decreased sensation in both feet, indicating possible progression of peripheral neuropathy and peripheral artery disease, common complications of poorly controlled diabetes.

Laboratory results reveal a hemoglobin A1c of 9.2%, confirming chronic hyperglycemia. Serum creatinine has increased to 1.6 mg/dL, suggesting declining renal function, while a urine microalbumin test returns positive, indicating early nephropathy. Lipid profile shows LDL cholesterol at 130 mg/dL and HDL cholesterol at 38 mg/dL, pointing to suboptimal control of dyslipidemia. These findings highlight the impact of persistent elevated glucose levels on microvascular and macrovascular health.

Given these developments, the healthcare team initiates a multidisciplinary approach. Neurology is consulted for the management of neuropathic pain, and a podiatrist is involved to address the foot ulcer and prevent further complications. Adjustments in the patient's diabetic management plan are considered, including the potential addition of a GLP-1 receptor agonist or SGLT2 inhibitor to improve glycemic control and cardiovascular outcomes. A referral to a dietitian is also made to optimize his nutritional intake and support weight management, a key factor in controlling diabetes-related complications. This integrated approach aims to mitigate the risk of further deterioration and improve the patient's quality of life.

Section 2

Response to Interventions:

Following the initiation of the multidisciplinary management plan, the patient begins to show signs of positive response, though with some areas of concern. The podiatrist's intervention in treating the plantar ulcer involves regular debridement and offloading techniques, alongside the application of specialized dressings to promote healing. Within two weeks, the ulcer shows signs of granulation tissue, indicating the beginning of the healing process. However, the patient's compliance with foot care education remains inconsistent, raising concerns about potential setbacks.

In terms of glycemic control, the addition of a GLP-1 receptor agonist to the patient's diabetes regimen results in a modest reduction in blood glucose levels. His fasting blood sugar has decreased from an average of 180 mg/dL to 150 mg/dL, and there is a slight improvement in his overall energy levels and mood. Despite these improvements, the patient's weight remains unchanged, highlighting the need for ongoing dietary adjustments and physical activity, as discussed with the dietitian. The patient expresses frustration over the restrictive dietary plan, which requires continuous encouragement and education to reinforce the importance of adherence for long-term benefits.

Neurologically, the patient reports a decrease in the intensity of the leg cramps at night, which can be attributed to the adjusted medication for neuropathic pain. However, the neurological assessment still reveals persistent diminished sensation and absent ankle reflexes, emphasizing the chronic nature of his peripheral neuropathy. The healthcare team continues to monitor renal function closely, observing that serum creatinine levels have stabilized but remain elevated, necessitating vigilant follow-up to prevent progression. These findings underscore the complexity of managing diabetes with complications and the critical need for ongoing, coordinated care to optimize outcomes and prevent further deterioration.

Section 3

As the multidisciplinary team continues to monitor the patient's progress, a new complication arises, necessitating immediate attention. During a routine follow-up visit, the patient's blood pressure is noted to be elevated consistently, with readings averaging 160/95 mmHg. This hypertensive state is concerning, particularly given the patient's existing diabetes-related complications. The nephrologist expresses concern about the potential impact on renal function, especially considering the already elevated serum creatinine levels. A 24-hour urine collection is ordered, revealing a significant increase in albuminuria, suggesting worsening nephropathy. The team decides to adjust the patient's antihypertensive regimen, introducing an ACE inhibitor to address both the hypertension and renal protection.

Simultaneously, the patient's recent laboratory results indicate a concerning trend in lipid profile, with an increase in LDL cholesterol to 145 mg/dL and triglycerides to 210 mg/dL. This dyslipidemia poses an additional risk factor for cardiovascular complications, prompting the team to discuss the initiation of a statin therapy. The patient expresses anxiety over the addition of more medications, highlighting the need for detailed education about the benefits and potential side effects of the new treatment. The nurse takes this opportunity to reinforce the importance of lifestyle modifications, emphasizing dietary changes and increased physical activity as integral components of managing both hypertension and dyslipidemia.

These developments in the patient's condition highlight the interconnected nature of diabetes management and its complications, underscoring the need for a comprehensive, individualized approach. The health care team remains vigilant, coordinating care across disciplines to address these evolving challenges. The patient's journey reflects the dynamic process of managing chronic illness, where each intervention and outcome informs the subsequent steps, guiding the team toward achieving optimal health outcomes.

Section 4

In the weeks following the initiation of the adjusted treatment regimen, the multidisciplinary team closely monitors the patient's response to the interventions. During a follow-up visit, a comprehensive assessment reveals mixed results. The patient's blood pressure has improved slightly, with readings now averaging 150/90 mmHg, indicating some initial positive response to the ACE inhibitor. However, the patient reports experiencing a persistent, dry cough, a known side effect of ACE inhibitors, which is impacting their quality of life and adherence to the medication regimen. The team discusses the possibility of switching to an angiotensin II receptor blocker (ARB) to alleviate this side effect while maintaining renal protection and blood pressure control.

Moreover, the patient's lipid profile shows a modest improvement, with LDL cholesterol decreasing to 130 mg/dL and triglycerides to 190 mg/dL following the introduction of statin therapy. Despite these changes, the patient continues to express concerns about medication burden and side effects, requiring ongoing education and support. The nurse plays a crucial role in addressing these concerns, providing clear explanations about the risk reduction benefits of the medications and reinforcing the importance of adherence to achieve long-term health goals.

Amid these developments, the patient reports new symptoms of mild peripheral neuropathy, characterized by tingling and numbness in the feet. This prompts the team to reassess the patient's glycemic control, as neuropathy is a common complication of poorly managed diabetes. A recent HbA1c test reveals a level of 8.2%, indicating suboptimal control. The endocrinologist suggests intensifying the diabetes management plan, which may involve adjusting the current medication or adding a new agent to better control blood glucose levels. This evolving situation underscores the complexity of diabetes management and the need for continuous adjustment of the treatment plan based on the patient's changing clinical status.

Section 5

Following the concerns about the patient's glycemic control and the development of mild peripheral neuropathy, the multidisciplinary team prioritizes addressing the elevated HbA1c level of 8.2%. The endocrinologist proposes modifying the diabetes management strategy by incorporating a sodium-glucose cotransporter-2 (SGLT2) inhibitor. This class of medication not only aids in reducing blood glucose levels but also provides cardiovascular and renal benefits, which could be advantageous given the patient's existing hypertension and mild renal impairment. The team ensures the patient understands the mechanism of the new medication, emphasizing the importance of monitoring for any potential side effects such as urinary tract infections or signs of dehydration, which are associated with SGLT2 inhibitors.

As the patient begins the new treatment regimen, the nurse closely monitors for any changes in symptoms or new adverse effects. In the subsequent weeks, the patient reports a decrease in the frequency of tingling and numbness in the feet, suggesting an initial positive response to the intensified glycemic management. The patient's blood glucose self-monitoring records show improved readings, with fasting levels averaging 110-130 mg/dL, indicating better daily control. However, the patient presents with new concerns during a follow-up visit, mentioning increased fatigue and occasional dizziness, especially when rising from a seated position.

These symptoms prompt the team to revisit the patient's blood pressure management, given the potential for orthostatic hypotension with the combination of medications, including the recently introduced SGLT2 inhibitor. A thorough examination reveals a postural drop in blood pressure, with readings of 140/88 mmHg while seated, dropping to 120/80 mmHg upon standing. The team decides to adjust the timing of the antihypertensive medication and advises the patient on strategies to alleviate dizziness, such as rising slowly from seated positions and ensuring adequate hydration. The patient is scheduled for another follow-up to reassess both blood pressure and glucose control, highlighting the need for ongoing monitoring and the potential for further adjustments to the treatment plan.